Scope

Appletree CI Group is a specialized CSO (Contract Service Organization) in Winterthur, Switzerland offering services in clinical research and regulatory aeffairs.

At Appletree CI Group we believe in focusing on what we know best. Our core business is the development of ophthalmological and dermatological medicines, as well as medical device investigations. In addition, we are experts in pediatric studies and we offer regulatory affairs services (DRA, RA) worldwide.

Appletree is the only contract research organization (CRO) in Europe with the combined expertise of medical devices and ophthalmology.

News & Events

3rd European Conference on Clinical Research, Prague CZ

We will be present at the EUCROF International Conference from October 17 – 18, 2016 in Prague (Czech Republic). Georg Mathis, our CEO & president, will be moderator for the session “Clinical Trials with Medical Devices”. For more information about this event click here.

Updated track records

We have updated our track records of clinical studies in medical devices and with pediatric population

Meet us at CPhI/iCSE in Barcelona

Appletree CI Group will be present with the booth no. 3B68 at the CPhI worldwide in Barcelona from 4th - 6th October 2016. Would you like to meet us there? Please click here.

Healthcare & Life Sciences Awards 2016

Appletree CI Group has been shortlisted for the Healthcare & Life Sciences Awards 2016. Click here to read more about it.

GCP course recognized by Swissethics

Appletree CI Group (ACG+) is offering a 2-day Good Clinical Practice (GCP) course, which is recognized by Swissethics as the basic training for Investigators and clinical site staff in Switzerland. Click here to read more about it.

New EU medical device rules will bring more consolidation - Interview with Georg Mathis, CEO of Appletree CI Group